European Medicines Agency (EMAfor its acronym in English) included heavy menstrual bleeding as a side effect of vaccination mRNA from Pfizer and Moderna against him Covid19.
Commission for risk assessment in pharmacovigilance (PRAC for the acronym in English) EMA concluded that immunizers cause an increase in the volume and/or duration of menstruation which “interferes with the physical, social, emotional and material quality of a person’s life.
These symptoms have been reported in humans after first and second inoculation, as well as with booster dose of Comirnaty and Spikevax, Pfizer or Moderna. However, most of the cases reviewed appear to be temporary and frivolous.
There is no evidence to suggest that the menstrual disorders experienced by some people have any effect on reproduction and fertility, explained the agency of the European Union in charge of evaluating medicines on the continent.
He also recommended his own use before and during pregnancy, as they also cause no complications for women or their babies and are effective in reducing the risk of hospitalization and death from Covid-19.
PARC recommended updating the product information following analysis of cases reported during clinical trials, as well as those reported to the EMA, and findings from the medical literature.
The Committee reiterated that all available data confirm that “the benefits of these vaccines far outweigh the risks.” However, the PRAC will continue to monitor cases of this condition and will advise if further recommendations are required.